Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-03

Clinical Trial Update: Effect of Evolocumab on Coronary Plaque Characteristics [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating evolocumab's effect on coronary plaque characteristics in coronary artery disease patients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evolocumab (evolocumab)

Snippet

Sponsor: Annapoorna Kini | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2023-05-03